Innovative Medicines and New Rules for the Financing of Treatments. What the Government Proposes
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Mateusz Oczkowski from the Ministry of Health cites the case of an innovative drug imported via targeted import, which cost tens of millions of zlotys over two years. Planned regulations will extend this procedure to refundable fees and overhaul the therapy financing system by mid-2027. We will discuss the future of drug and reimbursement policy during the Health Market Forum on October 26 and 27.
Patients with cancer and rare diseases could benefit from a clearer system of evaluation and financing of innovative treatments, and the state would check how effective medicines are and how much they cost before they are paid for public money. The project, which is to be examined by the Government on 21 October, includes special rules for rare diseases and serious cases, negotiations with producers and the possibility of recovering money if the…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
